Prevalence and rapid identification of clarithromycin-resistant Helicobacter pylori isolates in children

Pediatric Infectious Disease Journal

Volumn 20, Issue 7, 2001, Pages 662-666

  Yang, Yao Jong ^a,b   Yang, Jyh Chin ^a   Jeng, Yung Ming ^a   Chang, Mei Hwei ^a   Ni, Yen Hsuan ^a,c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Antibiotic resistance; Clarithromycin; Helicobacter pylori

Indexed keywords

CLARITHROMYCIN; METRONIDAZOLE; RIBOSOME RNA;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FEMALE; GASTRITIS; GASTROSCOPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MINIMUM INHIBITORY CONCENTRATION; POINT MUTATION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STOMACH ANTRUM; TAIWAN;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CLARITHROMYCIN; DNA, BACTERIAL; DRUG RESISTANCE, MICROBIAL; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEVERITY OF ILLNESS INDEX;

EID: 0034946064     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200107000-00005     Document Type: Article

References (22)

1. Helicobacter pylori, gastroduodenal disease, and recurrent abdominal pain in children
2. Helicobacter pylori infection and duodenal ulcer in children and adolescents
3. Effective 2-wk therapy for Helicobacter pylori disease in children
4. One-week proton pump inhibitor-based triple therapy eradicates residual Helicobacter pylori after failed dual therapy
5. Current European concepts in the management of Helicobacter pylori infection: The Maastricht consensus report
6. Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in the Netherlands
7. Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance
8. Evolution of resistance to metronidazole and clarithromycin in Helicobacter pylori clinical isolates from Spain
9. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline and trovafloxacin in the Netherlands
10. The prevalence of lymphoid follicles in Helicobacter pylori associated gastritis in patients with ulcers and non-ulcer dyspepsia
11. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori
12. Macrolide resistance in Helicobacter pylori: Rapid detection of point mutations and assays of macrolide binding to ribosomes
13. Direct detection of Helicobacter pylori resistance to macrolides by a polymerase chain reaction/DNA enzyme immunoassay in gastric biopsy specimens
14. Interleukin-8 activity correlates with histological severity in Helicobacter pylori associated antral gastritis
15. Bacterial density of Helicobacter pylori predicts the success of triple therapy in bleeding duodenal ulcer
16. Evaluation of the E test for quantitative antimicrobial susceptibility testing of Helicobacter pylori
17. Evolution of resistance of Helicobacter pylori to metronidazole and clarithromycin in Taiwan
18. Classification of grading of gastritis: The updated Sydney system 1994
19. Macrolide resistance in Helicobacter pylori: Mechanism and stability in strains from clarithromycin-treated patients
20. Molecular mechanisms of clarithromycin resistance in Helicobacter pylori
21. Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance
22. A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacterpylori